Sort
78,016 grants matching “breast cancer”
Preparation of sequencing libraries for multi-analyte analysis of RNAs
$1,020,220Sergei A Kazakov · Realseq Biosciences, Inc. · R44 · FY2025 · HG
Physical Activity, Energy Balance, and Cancer
$1,020,046Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Homology-directed repair: BRCA2 and RAD51 paralogs
$1,019,784Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Homology-directed repair: BRCA2 and RAD51 paralogs
$1,019,784Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
TARGETING THE EPITHELIAL TYPE II INTERLEUKIN-4 RECEPTOR IN METASTATIC BREAST CANCER
$1,019,572Vanderbilt University · · FY2016 · Department of the Army
CHARACTERIZING NITRO-FATTY ACIDS AS RAD51 INHIBITORS AND COTREATMENT IN TRIPLE-NEGATIVE BREAST CANCER.
$1,019,475University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2019 · Department of the Army
Leadership, Planning and Evaluation
$1,019,114Caryn Lerman · University Of Southern California · P30 · FY2022 · CA
Structual and function of kinase signaling complexes
$1,018,568Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Epidemiology of Putative Causal Variants in the Multiethnic Cohort
$1,018,523Loic Le Marchand · University Of Hawaii At Manoa · U01 · FY2009 · HG
Green Tea and Reduction of Breast Cancer Risk
$1,018,438Mindy Susan Kurzer · University Of Minnesota · R01 · FY2013 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$1,018,435Riverside Research Institute · R01 · FY2005 · CA
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St
$1,018,391Michael Clarke · Stanford University · U54 · FY2008 · CA
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$1,018,271Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2015 · ES
Oncogenic Kinase complexes
$1,018,257Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$1,018,170Martin Akerman · Envisagenics, Inc. · R44 · FY2022 · CA
Activating Cell Death Pathways in Breast Cancer Cells
$1,018,140Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Molecular linkages between epigenetic regulation and metabolism in breast cancer
$1,017,710Kevin Gardner · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Nanotechnology for Multiplexed and Intraoperative Cancer Detection
$1,017,561Shuming Nie · Emory University · RC2 · FY2010 · CA
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,017,359Carmelo J Rizzo · Vanderbilt University · P01 · FY2014 · CA
Molecular Analysis Of Cell Cycle Control During Carcinogenesis
$1,017,267Richard Paules · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$1,017,000Joan Siefert Brugge · Harvard Medical School · R35 · FY2020 · CA
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$1,017,000Joan Siefert Brugge · Harvard Medical School · R35 · FY2019 · CA
Biology and genetics of metastatic disease
$1,017,000Sohail F. Tavazoie · Rockefeller University · R35 · FY2025 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,016,525Irving Lerner Weissman · Stanford University · R35 · FY2021 · CA
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
$1,016,400Nicholas Schafer · Constantiam Biosciences Inc. · R44 · FY2024 · HG